Skip to main navigation Skip to search Skip to main content

A Phase 3 Open Label, Randomized, Multicenter Study of Treatment of Physician’s Choice (TPC) in Patients with Metastatic Breast Cancer Who have Stable Brain Metastases and have been Previously Treated with an Anthracycline, a Taxane, and Capecitabine.

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/16 → 1/1/20

Funding

  • Nektar Therapeutics